Wegovy cost at a glance (2026)
| Path | Cost / mo | Best for |
|---|---|---|
| Compounded semaglutide | $179-279 | Uninsured cash-pay (cheapest) |
| Wegovy Savings Card | $25 | Commercial insurance + covering plan |
| NovoCare (direct-to-patient) | $499 | Cash-pay, want brand-Novo product |
| GoodRx + retail | $1,200-1,300 | Modest savings on retail |
| Retail cash-pay | $1,349 | Almost never the right choice |
Path 1: Wegovy Savings Card — $25/month with commercial insurance
The Wegovy Savings Card is Novo Nordisk's manufacturer copay assistance program. Eligible commercially-insured patients pay as low as $25 per 28-day supply, with maximum savings of $225 per fill. This is the cheapest legitimate path for insured patients whose plan covers Wegovy.
Eligibility:
- Commercial (private) insurance that covers Wegovy
- US resident with valid prescription
- BMI ≥30, or BMI ≥27 with at least one weight-related comorbidity
- NOT eligible: Medicare, Medicaid, VA, Tricare, or any other federal/state insurance enrollee
Apply at wegovy.com. Card presented at the pharmacy applies the discount automatically.
Path 2: NovoCare — $499/month direct-to-patient cash-pay
NovoCare is Novo Nordisk's direct-to-patient pharmacy launched 2024 specifically to give cash-pay patients a more affordable Wegovy path. Sold through NovoCare at $499/month, this is dramatically cheaper than retail cash-pay ($1,349) and the cleanest brand-Novo path for uninsured patients.
How it works:
- Visit novocare.com to start the intake
- Connects you with a partner telehealth provider for the prescription
- Wegovy ships from NovoCare's pharmacy partner
- $499 covers the medication + telehealth consult bundled (varies by partner)
NovoCare prescribes through partner telehealth networks. Total all-in monthly cost including any separate consult fees typically lands at $500-600. Faster than navigating retail + insurance + PA, but more expensive than the manufacturer savings card path for insured patients.
Path 3: Compounded semaglutide — $179-279/month, the cheapest path
Compounded semaglutide is the same active ingredient as Wegovy, prepared by a state-licensed 503A pharmacy under FDA-permitted conditions. Programs like Direct Meds and Henry Meds offer compounded semaglutide at $179-279/month for cash-pay patients without insurance.
Important caveats:
- Compounded semaglutide is NOT FDA-approved as a standalone product
- It's legal when prepared by a registered 503A or 503B pharmacy under specific FDA conditions
- Quality varies by pharmacy — verify state board of pharmacy licensure before ordering
- FDA shortage status for semaglutide changes periodically; ongoing compounding requires careful pharmacy compliance
Path 4: GoodRx + retail pharmacy — modest savings
GoodRx coupons exist for Wegovy at most major retail pharmacies (CVS, Walgreens, Walmart, Costco). Discounts run 5-10% off retail, so cash-pay falls from $1,349 to roughly $1,200-1,300/month with a GoodRx code applied at the pharmacy counter.
For most patients, GoodRx is the wrong path for Wegovy — savings are too small relative to NovoCare ($499), the manufacturer savings card ($25 with insurance), or compounded semaglutide ($179-279). GoodRx makes sense only when none of the cheaper paths apply.
Path 5: Retail cash-pay — almost never the right choice
Brand-name Wegovy at retail without insurance: $1,349/month. This is Novo Nordisk's wholesale list price translated through the retail pharmacy markup. For uninsured cash-pay patients, this path is dominated by every other option in this guide.
Path 6: Patient Assistance Programs (PAPs) — uninsured low-income
Novo Nordisk's Patient Assistance Program provides free Wegovy to income-qualified uninsured patients (typically household income below 400% of federal poverty level). Application process takes 4-8 weeks.
For most uninsured patients, NovoCare ($499) is faster than navigating PAP eligibility. PAPs remain the right path for patients who genuinely cannot afford even the NovoCare rate.
What about insurance prior authorization?
Most commercial insurance plans require prior authorization (PA) for Wegovy:
- Documented BMI ≥30 (or ≥27 with comorbidity)
- Failed attempts at lifestyle intervention (most plans accept self-reported)
- Some plans require step-therapy through Saxenda first
- Some plans require periodic weight-loss documentation to maintain coverage
Telehealth providers with dedicated PA teams (Henry Meds, Mochi, Found, Hims) are the fastest path through the PA process.
FAQ
How much does Wegovy cost in 2026?
Wegovy retail cash-pay is approximately $1,349 for a 28-day supply. With the Wegovy Savings Card (commercial insurance required), eligible patients pay as low as $25/month. NovoCare, Novo Nordisk's direct-to-patient pharmacy, sells Wegovy at $499/month for cash-pay patients without insurance coverage. The cheapest legitimate alternative is compounded semaglutide at $179/month from state-licensed 503A pharmacies.
How much does Wegovy cost without insurance?
Three cash-pay options for uninsured patients: NovoCare at $499/month (the cheapest brand-name path), retail pharmacy with GoodRx at $1,200-1,300/month (modest savings off the $1,349 list), or compounded semaglutide at $179-279/month from a state-licensed 503A pharmacy (same active ingredient, not separately FDA-approved). Most uninsured patients prioritizing brand product use NovoCare; cost-prioritizing patients choose compounded.
Is the Wegovy Savings Card really $25 per month?
Yes, for eligible patients. The Wegovy Savings Card drops out-of-pocket cost to $25 per 28-day supply for commercially insured patients with covering plans. Maximum savings of $225 per fill. Federal-plan enrollees (Medicare, Medicaid, VA, Tricare) cannot use the savings card by federal anti-kickback law. For patients without commercial insurance or with non-covering insurance, the savings card doesn't apply.
What insurance covers Wegovy?
Most commercial insurance plans cover Wegovy for patients meeting FDA criteria (BMI ≥30, or BMI ≥27 with a weight-related comorbidity like hypertension, sleep apnea, dyslipidemia, or type 2 diabetes). Most plans require prior authorization. Some plans require step-therapy through Saxenda first. Medicare Part D does NOT cover Wegovy for weight loss (federal exclusion of obesity drugs); Medicare DOES cover Wegovy for patients with established cardiovascular disease (the SELECT trial indication added in March 2024).
How does Wegovy cost compare to Zepbound?
Wegovy retail is $1,349/month; Zepbound retail is $1,059/month — Zepbound is the cheaper brand-name option at retail. Both have manufacturer savings cards dropping commercial-insurance copay to $0-25/month. Cash-pay direct programs: NovoCare (Wegovy) $499, LillyDirect (Zepbound vials) $399. For most patients in 2026, Zepbound is the cheaper brand-name path; switching between them is reasonable practice when one is poorly tolerated.
What's the difference between Wegovy and compounded semaglutide?
Wegovy is FDA-approved branded semaglutide manufactured by Novo Nordisk in prefilled pens at standardized doses (0.25mg, 0.5mg, 1mg, 1.7mg, 2.4mg). Compounded semaglutide is the same active ingredient prepared by a state-licensed 503A pharmacy under specific FDA conditions, typically dispensed in vials with custom dose flexibility. The active ingredient is identical; the FDA-approval status, packaging, and price are different. Compounded semaglutide is dramatically cheaper ($179-279/mo vs $1,349 retail) but lacks the FDA's branded-product safety surveillance.
Are there Patient Assistance Programs (PAPs) for Wegovy?
Yes. Novo Nordisk's Patient Assistance Program provides free Wegovy to income-qualified uninsured patients (typically household income below 400% of federal poverty level). Application process takes 4-8 weeks; once approved, medication ships quarterly through participating prescribers. For most uninsured patients, NovoCare ($499/month) is faster than navigating PAP eligibility, but PAPs remain the right path for patients who genuinely cannot afford even the NovoCare rate.
Can I use a GoodRx coupon for Wegovy?
GoodRx coupons exist for Wegovy at most major retail pharmacies (CVS, Walgreens, Walmart, Costco). Discounts run 5-10% off retail, so cash-pay falls from $1,349 to roughly $1,200-1,300/month with a GoodRx code. The savings are real but modest compared to NovoCare ($499) or the manufacturer savings card ($25 with insurance). For most patients, GoodRx is the wrong path for Wegovy specifically.
Bottom line on Wegovy cost in 2026
For commercially insured patients with covering plans: $25/month via the savings card is the cheapest legitimate path. For cash-pay patients: $179-279/month for compounded semaglutide is the cheapest, with $499/month at NovoCare as the brand-Novo alternative. Retail cash-pay at $1,349/month is rarely justified.
Find my best Wegovy path →